How have SXTC shares performed in 2024?

China SXT Pharmaceuticals' stock was trading at $3.97 at the beginning of the year. Since then, SXTC stock has decreased by 70.5% and is now trading at $1.17. View the best growth stocks for 2024 here .

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 26,200 shares, an increase of 376.4% from the March 15th total of 5,500 shares. Based on an average trading volume of 546,600 shares, the short-interest ratio is presently 0.0 days. Approximately 4.8% of the company's stock are sold short. View China SXT Pharmaceuticals' Short Interest .

When is China SXT Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 29th 2024. View our SXTC earnings forecast .

When did China SXT Pharmaceuticals' stock split?

China SXT Pharmaceuticals's stock reverse split before market open on Thursday, October 5th 2023. The 1-25 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include iBio (IBIO) , Remark (MARK) , Aytu BioPharma (AYTU) , BIMI (BIMI) , My Size (MYSZ) , Nabriva Therapeutics (NBRV) , Sintx Technologies (SINT) and Sorrento Therapeutics (SRNE) .

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free SXTC Stock Alerts

$1.17

-0.23 (-16.43%)

(As of 04/15/2024 ET)

Compare

Today's Range: $1.10
▼
$1.37
50-Day Range: $1.17
▼
$2.21
52-Week Range: $1.10
▼
$9.38

Volume: 403,604 shs
Average Volume: 576,910 shs
Market Capitalization: $534,690.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines Ownership SEC Filings Short Interest Social Media

Get China SXT Pharmaceuticals alerts:

Ad InvestorPlace

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

>>Check out what this A.I. Perfect Storm is<<

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

SXTC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SXTC Stock News Headlines

February 23, 2024 | wsj.com

China SXT Pharmaceuticals Inc.

February 23, 2024 | benzinga.com

China SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider Trades

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

February 17, 2024 | finance.yahoo.com

China SXT Pharmaceuticals, Inc. (SXTC)

January 2, 2024 | markets.businessinsider.com

Dow Down 100 Points; US Manufacturing PMI Falls In December

December 31, 2023 | nasdaq.com

China SXT Pharma Continues To Spike

December 20, 2023 | morningstar.com

China SXT Pharmaceuticals Inc Ordinary Shares SXTC

October 26, 2023 | finance.yahoo.com

China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

October 26, 2023 | finance.yahoo.com

China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule

October 4, 2023 | finanznachrichten.de

China SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split

October 4, 2023 | markets.businessinsider.com

China SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5

October 4, 2023 | finance.yahoo.com

China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split

September 7, 2023 | investorplace.com

Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?

August 25, 2023 | seekingalpha.com

SXTC China SXT Pharmaceuticals, Inc.

August 21, 2023 | markets.businessinsider.com

Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?

August 2, 2023 | finance.yahoo.com

China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)

May 10, 2023 | finance.yahoo.com

China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

March 29, 2023 | finance.yahoo.com

Insiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% drop

January 10, 2023 | reuters.com

China says talks to include Paxlovid in its insurance drug list fail

January 5, 2023 | benzinga.com

China SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News Summary

May 18, 2022 | seekingalpha.com

China SXT Pharmaceuticals announces 1-for-20 reverse stock split

March 29, 2022 | investorplace.com

Why Is China SXT Pharmaceuticals (SXTC) Stock Up Today?

March 29, 2022 | seekingalpha.com

China SXT Pharmaceuticals climbs on heavy volume

March 15, 2022 | seekingalpha.com

China SXT Pharmaceuticals to raise $2.8M in convertible promissory note offering

March 14, 2022 | benzinga.com

China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million

January 20, 2022 | finance.yahoo.com

China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment

See More Headlines

Receive SXTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/15/2024
Next Earnings (Estimated): 7/29/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:SXTC
CUSIP: N/A
CIK: 1723980
Web: www.sxtchina.com
Phone: 8652386299087
Fax: N/A
Employees: 78
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.47
Quick Ratio: 1.41

Sales & Book Value

Annual Sales: $1.97 million
Price / Sales: 0.27
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $32.12 per share
Price / Book: 0.04

Miscellaneous

Outstanding Shares: 457,000
Free Float: 439,000
Market Cap: $534,690.00
Optionable: Not Optionable
Beta: 1.00

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Feng Zhou (Age 32)
Chairman of the Board & CEO
Comp: $50k
Mr. Xiaodong Pan (Age 46)
Chief Financial Officer
Comp: $50k
Mr. Jun Zheng (Age 46)
Executive Director

Key Competitors

View All Competitors

SXTC Stock Analysis - Frequently Asked Questions

How have SXTC shares performed in 2024?: China SXT Pharmaceuticals' stock was trading at $3.97 at the beginning of the year. Since then, SXTC stock has decreased by 70.5% and is now trading at $1.17.
View the best growth stocks for 2024 here.
Are investors shorting China SXT Pharmaceuticals?: China SXT Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 26,200 shares, an increase of 376.4% from the March 15th total of 5,500 shares. Based on an average trading volume of 546,600 shares, the short-interest ratio is presently 0.0 days. Approximately 4.8% of the company's stock are sold short.
View China SXT Pharmaceuticals' Short Interest.
When is China SXT Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, July 29th 2024.
View our SXTC earnings forecast.
When did China SXT Pharmaceuticals' stock split?: China SXT Pharmaceuticals's stock reverse split before market open on Thursday, October 5th 2023. The 1-25 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of China SXT Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include iBio (IBIO), Remark (MARK), Aytu BioPharma (AYTU), BIMI (BIMI), My Size (MYSZ), Nabriva Therapeutics (NBRV), Sintx Technologies (SINT) and Sorrento Therapeutics (SRNE).
How do I buy shares of China SXT Pharmaceuticals?: Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SXTC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

SXTC Stock Price History

SXTC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SXTC Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info